Investor Presentaiton

Nestlé 2023 Half-Year Results Thursday 27th July 2023 supported by Fortified milks and Dairy culinary solutions. Infant Nutrition saw double-digit growth, based on solid momentum for NAN and Nido growing-up milks. Coffee reported broad- based double-digit growth, supported by Nescafé soluble coffee. The Zone's underlying trading operating profit margin decreased by 130 basis points as one- off items in the prior year and cost inflation more than offset pricing and cost efficiencies Slide: Zone Greater China Turning to Zone Greater China. Organic growth was 4.7%, with pricing of 3.4% and RIG of 1.3%. Growth was supported by e-commerce momentum and a recovery of out-of-home channels. The Zone saw market share gains in Pet food and Confectionery. By product category, Nestlé Professional was the largest growth contributor, supported by innovation and distribution expansion. Infant Nutrition saw mid single-digit growth, led by NAN specialty offerings and illuma. Confectionery reported high single-digit growth, led by Hsu Fu Chi and Shark wafer. The Zone's underlying trading operating profit margin increased by 160 basis points as favorable mix and disciplined cost control more than offset cost inflation. Slide: Nestlé Health Science Turning next to Nestlé Health Science. The business posted mid-single-digit growth with pricing of 5.3% and RIG of -1.9%, following extraordinary growth over the last three years during the pandemic. Our three-year RIG average for the first half was 5.3%. E-commerce momentum, continued geographic expansion and market share gains supported growth. Consumer care reported a sales decrease, with a return to positive growth in the second quarter. Active nutrition saw low single-digit growth, driven by healthy aging products, Vital Proteins and Orgain. Vitamins, minerals and supplements saw a sales decrease in the first half, turning positive in the second quarter based on robust growth for Garden of Life and Pure Encapsulations. The VMS category is showing signs of returning to growth, and we expect it to increase further in the second half. Medical Nutrition recorded double-digit growth, with strong sales developments for acute medical care, pediatric and allergy products. 8

View entire presentation